Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Completed
GE Healthcare
N/A
2005-01-01
This study investigates whether there is a change in 123iodine-2ß-
carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with
levodopa compared to either dopamine agonist or placebo.
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Completed
Pfizer
N/A
2005-01-01
This study investigates whether there is a change in 123iodine-2ß-
carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with
levodopa compared to either dopamine agonist or placebo.
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Completed
Institute for Neurodegenerative Disorders
N/A
2005-01-01
This study investigates whether there is a change in 123iodine-2ß-
carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with
levodopa compared to either dopamine agonist or placebo.
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Completed
GE Healthcare
Phase 3
2003-11-01
The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT
scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB
dementia subjects determined by the clinical diagnosis of an independent expert consensus
panel used as the standard of truth.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
